Authors: JOQUEVIEL C MARTINO R GILARD V MALETMARTINO M CANAL P NIEMEYER U

Citation: C. Joqueviel et al., URINARY-EXCRETION OF CYCLOPHOSPHAMIDE IN HUMANS, DETERMINED BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Drug metabolism and disposition, 26(5), 1998, pp. 418-428

Authors: JOQUEVIEL C GILARD V MARTINO R MALETMARTINO M NIEMEYER U

Citation: C. Joqueviel et al., URINARY STABILITY OF CARBOXYCYCLOPHOSPHAMIDE AND CARBOXYIFOSFAMIDE, 2MAJOR METABOLITES OF THE ANTICANCER DRUGS CYCLOPHOSPHAMIDE AND IFOSFAMIDE, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 391-399

Authors: JOQUEVIEL C MALETMARTINO M MARTINO R

Citation: C. Joqueviel et al., A C-13 NMR-STUDY OF 2-C-13-CHLOROACETALDEHYDE, A METABOLITE OF IFOSFAMIDE AND CYCLOPHOSPHAMIDE, IN THE ISOLATED-PERFUSED RABBIT HEART MODEL- INITIAL OBSERVATIONS ON ITS CARDIOTOXICITY AND CARDIAC METABOLISM, Cellular and molecular biology, 43(5), 1997, pp. 773-782

Authors: JOQUEVIEL C GILARD V MALETMARTINO MC MARTINO R NIEMEYER U

Citation: C. Joqueviel et al., A P-31 NMR-STUDY OF THE STABILITY OF CARBOXYIFOSFAMIDE AND CARBOXYCYCLOPHOSPHAMIDE, 2 METABOLITES OF IFOSFAMIDE AND CYCLOPHOSPHAMIDE, Phosphorus, sulfur and silicon and the related elements, 111(1-4), 1996, pp. 716-716